Feed Preview

Inotropic Agents & Heart Disease

Inotropic Agents & Heart Disease diagram by StudioMolekuul, Shutterstock
StudioMolekuul, Shutterstock

Inotropic agents alter the force or energy of muscular contractions. Negatively inotropic agents weaken the force of muscular contractions. Positively inotropic agents increase the strength of muscular contraction. Inotropic agents are used in hospitalized patients with acute decompensated heart failure, with reduced left ventricular ejection fraction and with signs of end-organ dysfunction in the setting of a low cardiac output, or with severe systolic heart failure awaiting heart transplant to maintain hemodynamic stability or as a bridge to decision. Discover the latest research on inotrpic agents and heart diseases here.

Top 20 most recent papers
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society

A systematic review of the effect of regional anesthesia on diagnosis and management of acute compartment syndrome in long bone fractures

European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma SocietyFebruary 20, 2020
Andrew A TranGautam Siram
Anti-cancer Drugs

Investigation of the cytotoxic activity of two novel digitoxigenin analogues on H460 lung cancer cells

Anti-cancer DrugsFebruary 22, 2020
Laurita BoffCláudia Maria Oliveira Simões
Pharmacological Reports : PR

Itaconimides derivatives induce relaxation in mesenteric artery and negative inotropism by inhibition of CA2+ influx

Pharmacological Reports : PRFebruary 13, 2020
Raiana Dos Anjos MoraesDarizy Flávia Silva
Cardiology Research and Practice

Influence of Endogenous Cardiac Glycosides, Digoxin, and Marinobufagenin in the Physiology of Epithelial Cells

Cardiology Research and PracticeFebruary 25, 2020
Alejandro Ogazon Del ToroArturo Ponce
Journal of Cardiovascular Pharmacology

Comparison of positive inotropic agents in the management of acute decompensated heart failure

Journal of Cardiovascular PharmacologyFebruary 25, 2020
Julie KellyKenneth Lupi
bioRxiv

Phytochemical Screening and Antimicrobial Activity of Ziziphus spina-christi Stem Barks

bioRxivFebruary 25, 2020
Abdelrafie M. MakhawiHajer A. Uagoub
Heliyon

Phytochemical composition and antioxidant activity of coconut cotyledon

HeliyonFebruary 22, 2020
Udaya Prakash Nyayiru KannaianBhuvaneswari Srinivasan
The New Zealand Medical Journal

Intensive care unit utilisation post-oesophagectomy

The New Zealand Medical JournalFebruary 21, 2020
Michael O'GradyRoss Roberts
Phytochemistry

Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

PhytochemistryFebruary 20, 2020
Alistair T RichardsonNigel B Perry

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2020 Meta ULC. All rights reserved
/feed-previews/inotropic-agents-heart-disease/ac3dcd52-2258-4b2c-b6cc-2ab2f99bae46